LIFE 3.0 sp. z o.o. is implementing the project “FemiCode - Development of Predictive Models for Assessing Hormonal Health and the Risk of Disorders”, with support from European Union funds under SWPS University’s “Startup Booster for Social Impact” project, financed by the Polish Agency for Enterprise Development (PARP) under Priority II of the European Funds for a Modern Economy 2021-2027 Programme (FENG), in accordance with Grant Agreement No. FENG.02.28-IP.02-0003/23-00.
Project objectives and outcomes
We will develop a proprietary predictive model for the early detection of the risk of common women’s health disorders that are often diagnosed with delay, i.e. ovulation disorders, insulin resistance and premature menopause. As a result, the project will contribute to:
- reducing the time needed to diagnose disorders affecting quality of life and fertility (from 4 years to just a few weeks)
- increasing women’s health awareness, preventing infertility and improving well-being by promoting healthy behaviours
- increasing the early detection of underdiagnosed women’s health conditions and patient profiling
- optimising the patient pathway by directing patients to appropriate diagnostics and treatment in line with recommendations
- integrating the ecosystem of healthcare services related to hormonal health.
The solution is intended for women of reproductive age, as well as healthcare providers and companies operating in the health sector.
The project tasks include the development of predictive models, their pilot implementation and testing in real-world conditions, the development of B2C and B2B offerings, financial assumptions, a legal roadmap and a marketing strategy, as well as website development, active promotion of the solution and acquisition of the first contracts — with the aim of increasing the startup’s investment readiness.
Project value: PLN 430,648.50
European Funds contribution: PLN 372,008.58